macular degeneration

Showing 1 - 25 of 252

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diagnostic Possibilities in Ophthalmological Diseases Using

Recruiting
  • Retinal Disease
  • +2 more
  • SS-OCT system Plex Elite 9000
  • Linz, Oberösterreich, Austria
    Department for Ophthalmology and Optometry, Kepler University Ho
Oct 3, 2023

Macular Degeneration, Low Vision, Stargardt Disease Trial in Guangzhou (microperimetric biofeedback training)

Completed
  • Macular Degeneration
  • +2 more
  • microperimetric biofeedback training
  • Guangzhou, Guangdong, China
    MAIA microperimetry
Jun 6, 2023

Geographic Atrophy of the Macula, Macular Degeneration Trial in United States (AVD-104, Sham injection)

Not yet recruiting
  • Geographic Atrophy of the Macula
  • Macular Degeneration
  • Saint Petersburg, Florida
  • +4 more
Apr 20, 2023

Geographic Atrophy, Macular Degeneration Trial in United States (JNJ-81201887, Prednisone, Placebo)

Recruiting
  • Geographic Atrophy
  • Macular Degeneration
  • Phoenix, Arizona
  • +3 more
Mar 31, 2023

Geographic Atrophy Insights (i-GAIN) Natural History Study

Recruiting
  • Dry Age-related Macular Degeneration
  • +6 more
    • Belfast, United Kingdom
    • +11 more
    Mar 22, 2023

    Age-related Macular Degeneration, Macular Degeneration, Wet Macular Degeneration Trial in Germany, Switzerland (Brolucizumab)

    Recruiting
    • Age-related Macular Degeneration
    • +5 more
    • Brolucizumab
    • Regensburg, Bavaria, Germany
    • +32 more
    Jan 20, 2023

    Glaucoma, Macular Degeneration, Glaucoma Suspect Trial in Durham (Visual Performance tests, Brain-computer interface for

    Enrolling by invitation
    • Glaucoma
    • +5 more
    • Visual Performance tests
    • Brain-computer interface for assessment of multifocal steady-state visual evoked potentials
    • Durham, North Carolina
      Duke Eye Center
    Jan 19, 2023

    Macular Degeneration (AMD) Post-marketing Surveillance in Japan

    Completed
    • Macular Degeneration
    • Aflibercept(Eylea, VEGF Trap-Eye, BAY86-5321)
    • Multiple Locations, Japan
      (unnamed)
    Jan 9, 2023

    Macular Degeneration Trial in Bordeaux (MacuTest platform)

    Not yet recruiting
    • Macular Degeneration
    • MacuTest platform
    • Bordeaux, France
      CHU Bordeaux
    Dec 28, 2022

    Retinal Disease, Age-Related Macular Degeneration, Retinitis Pigmentosa Trial in Westport, Coral Springs, Dubai (Arm 1)

    Recruiting
    • Retinal Disease
    • +17 more
    • Arm 1
    • Westport, Connecticut
    • +2 more
    Nov 25, 2022

    Healthy, Macular Edema, Macular Degeneration Trial in Helsinki (ERG electrode tests for fundus image-guided focal ERG, Fundus

    Completed
    • Healthy
    • +2 more
    • ERG electrode tests for fundus image-guided focal ERG
    • Fundus image-guided focal ERG
    • Helsinki, Uusimaa, Finland
      Helsinki University Hospital, Retinal Outpatient Clinic
    Nov 7, 2022

    Glaucoma Eye, Macular Degeneration, Macula Abnormality Trial in Helsingborg (Hyperspectral retinal image, Mydriacyl Ophthalmic

    Enrolling by invitation
    • Glaucoma Eye
    • +3 more
    • Hyperspectral retinal image
    • Mydriacyl Ophthalmic Product
    • Helsingborg, Skåne Län, Sweden
      Sundets Ögonläkare
    Oct 20, 2022

    Macular Degeneration Trial (Zimura, Avastin, Lucentis)

    Completed
    • Macular Degeneration
    • (no location specified)
    Oct 4, 2022

    Geographic Atrophy, Macular Degeneration Trial in Dallas (Avacincaptad pegol 2 mg intravitreal injection)

    Not yet recruiting
    • Geographic Atrophy
    • Macular Degeneration
    • Avacincaptad pegol 2 mg intravitreal injection
    • Dallas, Texas
      Retina Foundation of the Southwest
    Sep 7, 2022

    Macular Degeneration Trial in United Kingdom, United States (BI 754132)

    Terminated
    • Macular Degeneration
    • BI 754132
    • Beverly Hills, California
    • +12 more
    Aug 23, 2022

    Glaucoma, Glaucoma Suspect, Diabetic Retinopathy Trial in Philadelphia (Free Eye Screenings, Enhanced Intervention, Usual Care)

    Completed
    • Glaucoma
    • +12 more
    • Free Eye Screenings
    • +2 more
    • Philadelphia, Pennsylvania
      Wills Eye Glaucoma Service
    Aug 19, 2022

    Macular Degeneration, Geographic Atrophy Trial in Worldwide (IONIS-FB-LRx, Placebo)

    Recruiting
    • Macular Degeneration
    • Geographic Atrophy
    • Phoenix, Arizona
    • +83 more
    Aug 19, 2022

    Central Visual Impairment, Macular Degeneration Trial in Birmingham (Training visual sensitivity, Combination training)

    Recruiting
    • Central Visual Impairment
    • Macular Degeneration
    • Training visual sensitivity
    • Combination training
    • Birmingham, Alabama
      UAB
    Aug 12, 2022

    Central Visual Impairment, Macular Degeneration Trial in Birmingham (Condition 1: Training visual sensitivity, Condition 2:

    Recruiting
    • Central Visual Impairment
    • Macular Degeneration
    • Condition 1: Training visual sensitivity
    • +3 more
    • Birmingham, Alabama
      UAB
    Aug 12, 2022

    Macular Degeneration, Central Visual Impairment Trial in Birmingham ('Scotoma awareness' Training, Control Training)

    Recruiting
    • Macular Degeneration
    • Central Visual Impairment
    • 'Scotoma awareness' Training
    • Control Training
    • Birmingham, Alabama
      UAB
    Jul 12, 2022

    Macular Degeneration Trial in Beijing (Autologous iPSC-derived RPE)

    Recruiting
    • Macular Degeneration
    • Autologous iPSC-derived RPE
    • Beijing, Beijing, China
      Beijing Tongren Hospitol,Capital Medical University
    Jun 30, 2022

    Ptosis, Macular Degeneration, Ametropia Trial in New York (Virtual Reality Headset)

    Recruiting
    • Ptosis
    • +2 more
    • Virtual Reality Headset
    • New York, New York
      New York Eye & Ear Infirmary of Mount Sinai
    Jun 22, 2022

    Macular Degeneration, Retinal Degeneration, Retinal Diseases Trial in Boston (Pistachio Group)

    Recruiting
    • Macular Degeneration
    • +3 more
    • Pistachio Group
    • Boston, Massachusetts
      Clinical and Translational Research Center (CTRC) - Tufts
    Jun 9, 2022

    Age-Related Maculopathy, Age-Related Maculopathies, Eye Diseases Trial in United States (RN6G, Placebo)

    Completed
    • Age-Related Maculopathy
    • +4 more
    • RN6G
    • Placebo
    • Campbell, California
    • +23 more
    May 10, 2022